These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37334053)

  • 1. A mechanistic pharmacokinetic model for intrathecal administration of antisense oligonucleotides.
    Linninger AA; Barua D; Hang Y; Iadevaia S; Vakilynejad M
    Front Physiol; 2023; 14():1130925. PubMed ID: 37334053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A physiologically-based pharmacokinetic model to describe antisense oligonucleotide distribution after intrathecal administration.
    Monine M; Norris D; Wang Y; Nestorov I
    J Pharmacokinet Pharmacodyn; 2021 Oct; 48(5):639-654. PubMed ID: 33991294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convective forces increase rostral delivery of intrathecal radiotracers and antisense oligonucleotides in the cynomolgus monkey nervous system.
    Sullivan JM; Mazur C; Wolf DA; Horky L; Currier N; Fitzsimmons B; Hesterman J; Pauplis R; Haller S; Powers B; Tayefeh L; DeBrosse-Serra B; Hoppin J; Kordasiewicz H; Swayze EE; Verma A
    J Transl Med; 2020 Aug; 18(1):309. PubMed ID: 32771027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single-cell map of antisense oligonucleotide activity in the brain.
    Mortberg MA; Gentile JE; Nadaf NM; Vanderburg C; Simmons S; Dubinsky D; Slamin A; Maldonado S; Petersen CL; Jones N; Kordasiewicz HB; Zhao HT; Vallabh SM; Minikel EV
    Nucleic Acids Res; 2023 Aug; 51(14):7109-7124. PubMed ID: 37188501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of mutant huntingtin-lowering antisense oligonucleotides to the brain by intranasally administered apolipoprotein A-I nanodisks.
    Aly AE; Caron NS; Black HF; Schmidt ME; Anderson C; Ko S; Baddeley HJE; Anderson L; Casal LL; Rahavi RSM; Martin DDO; Hayden MR
    J Control Release; 2023 Aug; 360():913-927. PubMed ID: 37468110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrier.
    Barker SJ; Thayer MB; Kim C; Tatarakis D; Simon MJ; Dial R; Nilewski L; Wells RC; Zhou Y; Afetian M; Akkapeddi P; Chappell A; Chew KS; Chow J; Clemens A; Discenza CB; Dugas JC; Dwyer C; Earr T; Ha C; Ho YS; Huynh D; Lozano EI; Jayaraman S; Kwan W; Mahon C; Pizzo M; Robles-Colmenares Y; Roche E; Sanders L; Stergioulis A; Tong R; Tran H; Zuchero Y; Estrada AA; Gadkar K; Koth CMM; Sanchez PE; Thorne RG; Watts RJ; Sandmann T; Kane LA; Rigo F; Dennis MS; Lewcock JW; DeVos SL
    Sci Transl Med; 2024 Aug; 16(760):eadi2245. PubMed ID: 39141703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diligent Design Enables Antibody-ASO Conjugates with Optimal Pharmacokinetic Properties.
    Sela T; Mansø M; Siegel M; Marban-Doran C; Ducret A; Niewöhner J; Ravn J; Martin RE; Sommer A; Lohmann S; Krippendorff BF; Ladefoged M; Indlekofer A; Quaiser T; Bueddefeld F; Koller E; Mohamed MY; Oelschlaegel T; Gothelf KV; Hofer K; Schumacher FF
    Bioconjug Chem; 2023 Nov; 34(11):2096-2111. PubMed ID: 37916986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Semi-Mechanistic Population Pharmacokinetic Model of Nusinersen: An Antisense Oligonucleotide for the Treatment of Spinal Muscular Atrophy.
    Biliouris K; Gaitonde P; Yin W; Norris DA; Wang Y; Henry S; Fey R; Nestorov I; Schmidt S; Rogge M; Lesko LJ; Trame MN
    CPT Pharmacometrics Syst Pharmacol; 2018 Sep; 7(9):581-592. PubMed ID: 30043511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal administration of antisense oligonucleotide against p38α but not p38β MAP kinase isoform reduces neuropathic and postoperative pain and TLR4-induced pain in male mice.
    Luo X; Fitzsimmons B; Mohan A; Zhang L; Terrando N; Kordasiewicz H; Ji RR
    Brain Behav Immun; 2018 Aug; 72():34-44. PubMed ID: 29128611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive Imaging of Antisense Oligonucleotides in the Brain via In Vivo Click Chemistry.
    Cook BE; Archbold J; Nasr K; Girmay S; Goldstein SI; Li P; Dandapani S; Genung NE; Tang SP; McClusky S; Plisson C; Afetian ME; Dwyer CA; Fazio M; Drury WJ; Rigo F; Martarello L; Kaliszczak M
    Mol Imaging Biol; 2022 Dec; 24(6):940-949. PubMed ID: 35655109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational and In Vitro Experimental Investigation of Intrathecal Drug Distribution: Parametric Study of the Effect of Injection Volume, Cerebrospinal Fluid Pulsatility, and Drug Uptake.
    Tangen KM; Leval R; Mehta AI; Linninger AA
    Anesth Analg; 2017 May; 124(5):1686-1696. PubMed ID: 28431428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System.
    Chen Y; Mazur C; Luo Y; Sun L; Zhang M; McCampbell A; Tomassy GS
    J Vis Exp; 2019 Oct; (152):. PubMed ID: 31736489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain pharmacology of intrathecal antisense oligonucleotides revealed through multimodal imaging.
    Mazur C; Powers B; Zasadny K; Sullivan JM; Dimant H; Kamme F; Hesterman J; Matson J; Oestergaard M; Seaman M; Holt RW; Qutaish M; Polyak I; Coelho R; Gottumukkala V; Gaut CM; Berridge M; Albargothy NJ; Kelly L; Carare RO; Hoppin J; Kordasiewicz H; Swayze EE; Verma A
    JCI Insight; 2019 Oct; 4(20):. PubMed ID: 31619586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic Modeling of Intrathecal Chemotherapy Pharmacokinetics in the Human Central Nervous System.
    Li J; Wu A; Kim S
    Clin Cancer Res; 2024 Apr; 30(7):1397-1408. PubMed ID: 38289997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fluorescent splice-switching mouse model enables high-throughput, sensitive quantification of antisense oligonucleotide delivery and activity.
    Byrnes AE; Roudnicky F; Gogineni A; Soung AL; Xiong M; Hayne M; Heaster-Ford T; Shatz-Binder W; Dominguez SL; Imperio J; Gierke S; Roberts J; Guo J; Ghosh S; Yu C; Roose-Girma M; Elstrott J; Easton A; Hoogenraad CC
    Cell Rep Methods; 2024 Jan; 4(1):100673. PubMed ID: 38171361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Metabolism and Pharmacokinetics of Antisense Oligonucleotide Therapeutics: Typical Profiles, Evaluation Approaches, and Points to Consider Compared with Small Molecule Drugs.
    Takakusa H; Iwazaki N; Nishikawa M; Yoshida T; Obika S; Inoue T
    Nucleic Acid Ther; 2023 Apr; 33(2):83-94. PubMed ID: 36735616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vivo Intrathecal Tracer Dispersion in Cynomolgus Monkey Validates Wide Biodistribution Along Neuraxis.
    Tangen K; Nestorov I; Verma A; Sullivan J; Holt RW; Linninger AA
    IEEE Trans Biomed Eng; 2020 Apr; 67(4):1122-1132. PubMed ID: 31352328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense oligonucleotides on neurobehavior, respiratory, and cardiovascular function, and hERG channel current studies.
    Kim TW; Kim KS; Seo JW; Park SY; Henry SP
    J Pharmacol Toxicol Methods; 2014; 69(1):49-60. PubMed ID: 24211663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal Delivery of Therapeutic Oligonucleotides for Potent Modulation of Gene Expression in the Central Nervous System.
    Kennedy Z; Gilbert JW; Godinho BMDC
    Methods Mol Biol; 2022; 2434():345-353. PubMed ID: 35213030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of a central nervous system delivered 2'-O-methoxyethyl-modified survival of motor neuron splicing oligonucleotide in mice and nonhuman primates.
    Rigo F; Chun SJ; Norris DA; Hung G; Lee S; Matson J; Fey RA; Gaus H; Hua Y; Grundy JS; Krainer AR; Henry SP; Bennett CF
    J Pharmacol Exp Ther; 2014 Jul; 350(1):46-55. PubMed ID: 24784568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.